metformin has been researched along with Catastrophic Illness in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Catastrophic Illness: An acute or prolonged illness usually considered to be life-threatening or with the threat of serious residual disability. Treatment may be radical and is frequently costly.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amiresmaili, M | 1 |
| Emrani, Z | 1 |
1 other study available for metformin and Catastrophic Illness
| Article | Year |
|---|---|
Investigating the exposure of Iranian households to catastrophic health expenditure due to the need to purchase medicines.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Atorvastatin; Catastrophic Illness; Cross-Sectional Stu | 2019 |